VACCHI, CATERINA
 Distribuzione geografica
Continente #
NA - Nord America 6.935
EU - Europa 6.780
AS - Asia 3.844
SA - Sud America 612
AF - Africa 135
OC - Oceania 82
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.390
Nazione #
US - Stati Uniti d'America 6.623
IT - Italia 4.225
SG - Singapore 1.147
CN - Cina 853
GB - Regno Unito 640
SE - Svezia 440
BR - Brasile 426
HK - Hong Kong 378
VN - Vietnam 360
DE - Germania 279
FR - Francia 209
RU - Federazione Russa 206
CA - Canada 199
BD - Bangladesh 197
FI - Finlandia 181
IN - India 157
NL - Olanda 151
JP - Giappone 137
TR - Turchia 137
KR - Corea 117
ID - Indonesia 94
UA - Ucraina 83
AU - Australia 74
MX - Messico 73
IE - Irlanda 64
AR - Argentina 63
BG - Bulgaria 59
PK - Pakistan 48
TN - Tunisia 47
PL - Polonia 43
EC - Ecuador 36
IQ - Iraq 34
MY - Malesia 31
ZA - Sudafrica 30
LT - Lituania 26
ES - Italia 25
CL - Cile 20
CO - Colombia 20
AT - Austria 19
PE - Perù 19
AE - Emirati Arabi Uniti 16
EG - Egitto 16
IR - Iran 16
SA - Arabia Saudita 16
JO - Giordania 15
BE - Belgio 13
HU - Ungheria 13
PT - Portogallo 13
VE - Venezuela 13
CH - Svizzera 11
PH - Filippine 11
TH - Thailandia 11
DK - Danimarca 10
KE - Kenya 10
RO - Romania 10
DZ - Algeria 9
IL - Israele 9
NP - Nepal 9
BZ - Belize 8
CZ - Repubblica Ceca 8
LU - Lussemburgo 8
MA - Marocco 8
NZ - Nuova Zelanda 8
OM - Oman 8
PY - Paraguay 8
TW - Taiwan 8
UZ - Uzbekistan 7
HN - Honduras 6
HR - Croazia 6
RS - Serbia 6
BO - Bolivia 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CY - Cipro 4
GR - Grecia 4
JM - Giamaica 4
MD - Moldavia 4
AL - Albania 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EE - Estonia 3
LV - Lettonia 3
PA - Panama 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
GY - Guiana 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MN - Mongolia 2
MU - Mauritius 2
NI - Nicaragua 2
Totale 18.364
Città #
Singapore 774
Santa Clara 740
Ashburn 704
Fairfield 591
Chandler 419
Hong Kong 362
Milan 333
Rome 306
San Jose 290
Southend 285
Woodbridge 262
Nyköping 245
Houston 207
Hefei 183
Council Bluffs 178
Wilmington 174
Seattle 171
Beijing 170
London 167
Cambridge 162
Helsinki 155
New York 152
Ann Arbor 141
Los Angeles 141
The Dalles 121
Chicago 106
Bologna 101
Ho Chi Minh City 91
Seoul 88
Hanoi 87
Naples 81
San Diego 72
Florence 69
Jacksonville 68
Modena 68
Jakarta 67
Toronto 67
Bari 59
Catania 59
Shanghai 57
Sofia 57
Dallas 55
Dearborn 55
Palermo 52
Redwood City 52
Dublin 50
Tokyo 50
Bremen 49
Princeton 49
Buffalo 47
Moscow 47
Perth 47
Frankfurt am Main 44
Lauterbourg 42
São Paulo 42
Turin 42
Munich 41
North York 37
Salt Lake City 37
Verona 37
Orem 36
Genoa 34
Cagliari 32
Izmir 30
Atlanta 28
Eugene 27
Manchester 27
Chennai 26
Padova 25
Falls Church 24
Ankara 23
Columbus 23
Guayaquil 23
Salerno 23
Warsaw 23
Mexico City 22
Parma 22
Da Nang 21
Mumbai 20
Phoenix 20
Boardman 19
Denver 19
Istanbul 19
Brescia 18
Reggio Emilia 18
Rio de Janeiro 18
Bergamo 17
Boston 17
Brooklyn 17
Tampa 17
Treviso 17
Venice 17
Elk Grove Village 16
Haiphong 16
Johannesburg 16
Pisa 16
Santiago 16
Delhi 15
Baghdad 14
Beauharnois 14
Totale 10.350
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.855
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.362
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 516
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 372
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 372
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 348
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 345
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 341
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 323
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 318
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 309
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 302
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 295
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 289
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 288
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 286
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 284
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 283
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 282
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 270
PREVALENZA, CORRELATI CLINICO-SEROLOGICI E CARATTERISTICHE RADIOLOGICHE DELL'INTERSTIZIOPATIA POLMONARE IN UN'AMPIA COORTE DI PAZIENTI AFFETTI DA SINDROME DI SJOGREN 264
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 255
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 253
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 247
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 244
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 241
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 238
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis 229
Procedural pain management in the treatment of scleroderma digital ulcers 229
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 228
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 227
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 219
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 205
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 203
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 202
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study 200
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 200
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 198
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 195
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 187
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 185
Vasculitis in a patient with mixed cryoglobulinemia treated with rituximab biosimilar CT-P10: a case report 183
THU0289 PERSISTENCE OF CIRCULATING CRYOGLOBULINS AND RELATED SYMPTOMS AFTER HEPATITIS C VIRUS ERADICATION IN PATIENTS WITH MIXED CRYOGLOBULIN SYNDROME 182
Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey 179
Fibrosing interstitial lung disease in primary Sjogren syndrome 171
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 169
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 162
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia 154
Erratum: Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: A case report and review of the literature (Clinical Rheumatology (2013) 32 (905-907) DOI: 10.1007/s10067-013-2229-z) 153
Pneumopathie interstitielle fibrosante dans le syndrome de Gougerot-Sjögren primitif 144
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 141
COVID-19 VACCINATION RATE AND SAFETY PROFILE IN PATIENTS AFFECTED BY MIXED CRYOGLOBULINEMIC VASCULITIS 136
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients 132
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 128
POS1053 PREVALENCE OF FIBROSING PROGRESSIVE INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS PATIENTS 121
Reply to “ Sjögren's syndrome and pulmonary hypertension: Correspondence” 111
Sjögren's syndrome and pulmonary hypertension: Exploring the intricate link with interstitial lung disease 103
Reply to “Considerations on Patient Age in the Study of Pulmonary Hypertension and Interstitial Lung Disease in Sjögren's Syndrome” 96
PROPOSAL OF CORE OUTCOME DOMAINS IN MIXED CRYOGLOBULINEMIC VASCULITIS 96
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 93
Real-World Use of Anifrolumab for Articular Involvement in Systemic Lupus Erythematosus: A Monocentric Case Series and Systematic Review 68
Personalized Medicine and Machine Learning: A Roadmap for the Future 60
Hemoglobin-to-Red Cell Distribution Width Ratio and Vitamin D Status as Early Predictors of Cardiovascular Risk in Primary Sjögren’s Syndrome 49
Beyond systemic lupus erythematosus: a systematic review on the use of belimumab in other connective tissue diseases and vasculitides 45
HCV-related cryoglobulinemic vasculitis (mixed cryoglobulinemia syndrome) in the era of direct-acting antivirals: A 10-year experience from Italian tertiary referral centers 13
Totale 18.578
Categoria #
all - tutte 62.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021148 0 0 0 0 0 0 0 0 0 0 0 148
2021/20221.607 126 83 106 92 113 145 87 87 183 118 243 224
2022/20232.350 235 187 153 161 227 208 165 236 240 133 243 162
2023/20242.467 126 138 165 256 275 252 237 348 75 128 215 252
2024/20253.679 187 117 159 260 589 499 355 227 376 153 327 430
2025/20265.615 359 201 413 654 781 415 649 279 574 499 471 320
Totale 18.578